Estrella Immunopharma (ESLA) Stock Chart & Stock Price History → Biotech's Best Kept Secret: Potential 46,751% Gain (From Behind the Markets) (Ad) Free ESLA Stock Alerts $0.95 +0.07 (+7.98%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsOwnershipSEC FilingsShort InterestTrends Estrella Immunopharma Stock Price Performance5 Day Performance-3.69%1 Month Performance-10.00%3 Month Performance-11.10%6 Month Performance-34.70%Year-To-Date Performance-14.70% Receive ESLA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsBiotech's Best Kept Secret: Potential 46,751% GainThe world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>> ESLA Stock Chart for Sunday, June, 2, 2024 ESLA Chart by TradingView Estrella Immunopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.88$0.95+7.59%$0.98$0.887,756 shs$34.45 million05/30/2024$1.01$0.88-12.87%$0.99$0.8841,931 shs$32.01 million05/29/2024$0.98$1.01+2.74%$1.02$0.957,163 shs$36.74 million05/28/2024$0.99$0.98-0.90%$0.99$0.986,726 shs$35.77 million05/27/2024$0.99$0.99$1.02$0.9424,100 shs$36.09 million05/24/2024$1.00$0.99-0.80%$1.02$0.9424,153 shs$36.09 million Get the Latest News and Ratings for ESLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$1.02$1.00-1.48%$1.05$0.9811,599 shs$36.38 million05/22/2024$0.99$1.02+2.53%$1.04$0.985,250 shs$36.93 million05/21/2024$1.05$0.99-5.71%$1.05$0.986,648 shs$36.02 million05/20/2024$1.02$1.05+3.44%$1.05$0.9810,158 shs$38.20 million05/17/2024$1.05$1.02-3.33%$1.12$0.8624,530 shs$37.16 million05/16/2024$1.08$1.05-2.78%$1.08$1.0017,266 shs$38.44 million05/15/2024$1.05$1.08+3.35%$1.13$1.018,349 shs$39.54 million05/14/2024$1.07$1.05-2.34%$1.13$1.015,809 shs$38.26 million05/13/2024$1.08$1.07-0.93%$1.12$1.0112,473 shs$39.17 million05/10/2024$1.07$1.08+0.93%$1.10$1.046,020 shs$39.54 million05/09/2024$1.08$1.07-0.93%$1.07$1.07526 shs$39.17 million05/08/2024$1.03$1.08+4.85%$1.08$1.051,127 shs$39.54 million05/07/2024$1.00$1.03+3.00%$1.08$1.0015,219 shs$37.71 million05/06/2024$1.00$1.00$1.07$1.0011,477 shs$36.61 million05/03/2024$1.05$1.00-4.94%$1.08$1.0011,295 shs$36.61 million05/02/2024$1.05$1.05+0.19%$1.06$1.018,726 shs$38.51 million05/01/2024$1.05$1.05$1.09$1.0111,326 shs$38.44 million04/30/2024$1.07$1.05-1.78%$1.08$1.0119,522 shs$38.44 million04/29/2024$1.02$1.07+4.80%$1.08$1.0212,785 shs$39.14 million04/26/2024$1.04$1.02-1.92%$1.07$1.0214,309 shs$37.34 million04/25/2024$1.12$1.04-7.14%$1.07$1.041,119 shs$38.08 million04/24/2024$1.03$1.12+8.74%$1.12$1.0810,206 shs$41.00 million04/23/2024$1.07$1.03-3.29%$1.08$1.031,273 shs$37.71 million04/22/2024$1.07$1.07-0.47%$1.12$1.063,797 shs$38.99 million04/19/2024$1.03$1.07+3.88%$1.07$0.998,938 shs$39.17 million04/18/2024$1.12$1.03-8.04%$1.13$1.0062,213 shs$37.71 million04/17/2024$1.09$1.12+3.23%$1.12$1.033,869 shs$41.00 million04/16/2024$1.06$1.09+2.36%$1.14$1.022,932 shs$39.72 million04/15/2024$1.13$1.06-6.19%$1.22$1.0616,675 shs$38.81 million04/12/2024$1.09$1.13+3.67%$1.13$1.102,971 shs$41.37 million04/11/2024$1.15$1.09-5.22%$1.17$1.0827,948 shs$39.91 million04/10/2024$1.10$1.15+4.55%$1.20$1.0718,219 shs$42.10 million04/09/2024$1.10$1.10$1.21$1.0620,981 shs$40.27 million04/08/2024$1.15$1.10-4.35%$1.21$1.1024,152 shs$40.27 millionBiotech's Best Kept Secret: Potential 46,751% Gain (Ad)The world's #1 biotech investor has been praising this stock since it was just $18.56. Even though it's rocketed 266% this year, he's now recommending a different biotech entirely!Get the name of the stock here >>>04/05/2024$1.14$1.15+0.88%$1.16$1.082,247 shs$42.10 million04/04/2024$1.22$1.14-6.55%$1.21$1.0721,762 shs$41.74 million04/03/2024$1.23$1.22-0.82%$1.22$1.1118,500 shs$44.66 million04/02/2024$1.26$1.23-2.38%$1.27$1.106,152 shs$45.03 million04/01/2024$1.24$1.26+1.61%$1.31$1.1633,769 shs$46.13 million03/29/2024$1.24$1.24$1.26$1.2020,903 shs$45.40 million03/28/2024$1.25$1.24-0.80%$1.26$1.2020,902 shs$45.40 million03/27/2024$1.26$1.25-0.76%$1.25$1.0827,869 shs$45.76 million03/26/2024$1.13$1.26+11.47%$1.26$1.1643,264 shs$46.12 million03/25/2024$1.15$1.13-1.74%$1.15$1.125,672 shs$41.37 million03/22/2024$1.08$1.15+6.48%$1.18$1.063,875 shs$42.10 million03/21/2024$1.04$1.08+3.84%$1.25$1.0355,105 shs$39.54 million03/20/2024$1.10$1.04-5.45%$1.11$1.0418,458 shs$38.08 million03/19/2024$1.10$1.10$1.13$1.0818,986 shs$40.27 million03/18/2024$1.11$1.10-0.90%$1.15$1.0810,115 shs$40.27 million03/15/2024$1.03$1.11+7.77%$1.14$1.0333,018 shs$40.64 million03/14/2024$1.10$1.03-6.36%$1.12$1.0352,364 shs$37.71 million03/13/2024$1.19$1.10-7.56%$1.19$1.0673,187 shs$40.27 million03/12/2024$0.98$1.19+21.43%$1.40$0.98372,650 shs$43.57 million03/11/2024$1.04$0.98-5.77%$1.06$0.9678,762 shs$35.88 million03/08/2024$1.07$1.04-2.79%$1.16$1.0081,578 shs$38.07 million03/07/2024$1.13$1.07-5.32%$1.17$0.9584,239 shs$39.17 million03/06/2024$1.01$1.13+11.88%$1.20$0.92119,331 shs$41.37 million03/05/2024$1.01$1.01$1.03$0.9615,504 shs$36.98 million03/04/2024$1.07$1.01-5.16%$1.08$0.8632,278 shs$36.98 million03/01/2024$1.02$1.07+4.41%$1.09$1.0216,740 shs$38.99 million Related Companies: Molecular Partners Stock Chart BioCardia Stock Chart Vigil Neuroscience Stock Chart aTyr Pharma Stock Chart Sangamo Therapeutics Stock Chart Omega Therapeutics Stock Chart DBV Technologies Stock Chart Athira Pharma Stock Chart bluebird bio Stock Chart JATT Acquisition Stock Chart Receive ESLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ESLA) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.